日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

FGFR1/YAP1 signaling in endothelial cells drives renal fibrosis and offers a therapeutic target

内皮细胞中的FGFR1/YAP1信号通路驱动肾纤维化，并可作为治疗靶点。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2026.1766265
Jiang, Xin; Ren, Yafeng; Yan, Mengli; Li, Mingjing; Cao, Huixia; Shao, Fengmin
信号转导
FGFR1
细胞生物学
YAP
YAP1
内皮细胞
发表日期：2026
文献求助 收藏

Associations of frailty with the incidence and progression trajectory of cardiometabolic-kidney multimorbidity: insights from multi-state modelling

虚弱与心血管代谢-肾脏多重疾病的发生率和进展轨迹之间的关联：来自多状态模型的启示

期刊:Journal of Global Health
影响因子:4.3
doi:10.7189/jogh.16.04133
Han, Minghui; Zhou, Jing; Bai, Wenxin; Wan, Zhenzhen; Chen, Meng; Yan, Mengli; Feng, Wei; Wang, Ge; Zhang, Jing; Zhang, Lina; Yan, Lei; Shao, Fengmin; Gu, Yue
代谢
发表日期：2026
文献求助 收藏

Construction and Validation of a Nomogram Based on Preoperative Inflammatory Indicators for Predicting Acute Kidney Injury After Pancreaticoduodenectomy

基于术前炎症指标构建和验证预测胰十二指肠切除术后急性肾损伤的列线图

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S588367
Zhang, Wenwen; Qin, Zengyuan; Wang, JunTao; Huang, Chunling; Zhao, Xiaoru; Liu, Ziyang; Wang, Limeng; Yan, Lei; Gu, Yue; Shao, Fengmin
炎症
炎症/感染
肾损伤
毒理研究
发表日期：2026
文献求助 收藏

First-line and Second-line Therapy of Zuberitamab in Idiopathic Membranous Nephropathy: A Single-center Retrospective Study

祖贝利单抗一线和二线治疗特发性膜性肾病：单中心回顾性研究

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2025.101182
Wang, Linna; Yang, Miaomiao; Yan, Lei; Shao, Fengmin
发表日期：2026
文献求助 收藏

Combination of B-cell-guided rituximab and low-dose tacrolimus for primary membranous nephropathy: a retrospective cohort study

B细胞引导的利妥昔单抗联合低剂量他克莫司治疗原发性膜性肾病：一项回顾性队列研究

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1761271
Wang, Lijiao; Huo, Shuai; You, Zhenzhen; Dong, Yang; Gan, Yuan; Zhang, Zhu; Gu, Yue; Yan, Lei; Shao, Fengmin
B细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Renal-clearable and mitochondria-targeted metal-engineered carbon dot nanozymes for regulating mitochondrial oxidative stress in acute kidney injury

肾脏可清除且靶向线粒体的金属工程碳点纳米酶用于调节急性肾损伤中的线粒体氧化应激

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.101717
Pan, Jiangpeng; Wang, Juntao; Wang, Wei; Liu, Ziyang; Huo, Shuai; Yan, Lei; Jiang, Wei; Shao, Fengmin; Gu, Yue
毒理研究
线粒体
肾损伤
氧化应激
发表日期：2025
文献求助 收藏

The N(1)-methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds

N(1)-甲基腺苷甲基转移酶TRMT61A促进膀胱癌进展，并可作为小分子化合物的靶点。

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70137
Yin, Jianjian; Fan, Xin; Chang, Qi; Dai, Yuanheng; Wang, Tao; Shi, Lei; Yang, Linlin; Yang, Xiaoming; Zhang, Xudong; Jin, Lei; Liu, Tao; Shao, Fengmin; Zhang, Lirong; Song, Dongkui
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC.

基于单细胞和批量 RNA 测序的细胞层级框架揭示脂肪酸代谢生物标志物 MYDGF 是 ccRCC 的治疗靶点

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1615601
Wang Ning, Xu Ziyu, Zhang Lina, Lu Yanfang, Wang Yanliang, Yan Lei, Cao Huixia, Wang Limeng, Shao Fengmin
代谢
细胞生物学
单细胞
发表日期：2025
文献求助 收藏

Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non-Dialysis-Dependent CKD-Associated Anemia

低剂量罗沙司他治疗非透析依赖性慢性肾病相关性贫血的随机试验

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2025.01.027
Li, Ping; Sun, Xuefeng; Zhang, Li; Lin, Hongli; Wang, Niansong; Li, Yuehong; Zhao, Sumei; Fu, Ping; Cheng, Hong; Guo, Zhiyong; Lu, Wanhong; He, Yani; Shao, Fengmin; He, Qiang; Wu, Yiqing; Huang, Cuihua; Pan, Shuting; Cai, Guangyan; Chen, Xiangmei
贫血
代谢
发表日期：2025
文献求助 收藏

Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study

泰利他西普治疗IgA肾病的疗效和安全性：一项单中心真实世界研究

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1642137
Tao, Lin; Zhang, Xiaoling; Niu, Xiaoge; Liu, Gailing; Jiao, Xiaojing; Shao, Fengmin; Cao, Huixia
IgA
发表日期：2025
文献求助 收藏